首页> 外国专利> NOVEL USE OF COMBINATION OR COMPOSITION OF PANAX NOTOGINSENG AND ASPIRIN

NOVEL USE OF COMBINATION OR COMPOSITION OF PANAX NOTOGINSENG AND ASPIRIN

机译:三七人参与阿司匹林的组合使用

摘要

An application of a combination or composition of Panax notoginseng Radix et Rhizoma Notoginseng and aspirin in the preparation of a drug for preventing and treating cardiovascular and cerebrovascular diseases, the combination or composition being as follows: the dose range of Panax notoginsenoside Radix et Rhizoma Notoginseng is 25-500 mg/d, and the dose range of aspirin is 20-700 mg/d. The Panax notoginseng Radix et Rhizoma Notoginseng comprises commercially available product products, Panax notoginseng herb Radix et Rhizoma Notoginseng, a Panax notoginseng an extract prepared from Radix et Rhizoma Notoginseng, a Panax notoginseng an active component, ingredient of Radix et Rhizoma Notoginseng and a Panax notoginseng preparation thereof of Radix et Rhizoma Notoginseng, and so on. Panax notoginseng Radix et Rhizoma Notoginseng and aspirin have a synergistic effect, while reducing gastric mucosal damage caused by aspirin.
机译: Panax notoginseng Radix et Rhizoma Notoginseng 和阿司匹林的组合或组合物在制备用于预防和治疗心脑血管疾病的药物中的组合或组合物如下: Panax 三七皂苷Radix et Rhizoma 三七皂苷的剂量范围为25-500 mg / d,阿司匹林的剂量范围为20-700 mg / d。 Panax三七 Radix et Rhizoma 三七包括市售产品产品 Panax三七 herb Radix et Rhizoma 三七 Panax三七是从Radix et Rhizoma Notoginseng 提取的提取物,它是 Panax三七的活性成分,是Radix et Rhizoma 三七的成分 I>以及Radix et Rhizoma Notoginseng Panax三七制备等。 Panax三七 Radix et Rhizoma 三七和阿司匹林具有协同作用,同时减少了阿司匹林对胃粘膜的损害。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号